V9HW37 (V9HW37_HUMAN) Homo sapiens (Human)

T-complex protein 1 subunit epsilon UniProtKBInterProInteractive Modelling

541 aa; Sequence (Fasta) ; 18 identical sequences

Available Structures

53 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
CCT G beta 5 complex closed state 14 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 3 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex best PhLP1 class Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 4 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 6 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 13 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex intermediate state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-541
16×ADP;
Assess
CCT G beta 5 complex closed state 12 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 15 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 5 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex close state 11 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 2 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 10 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 8 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
Human TRiC complex in closed state with nanobody Nb18, actin and PhLP2A bound Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P63261; P78371; Q99832; Q9H2J4;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 0 Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT-G beta 5 complex closed state 7 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 1 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
CCT G beta 5 complex closed state 9 Heteromer
O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-541
16×ADP; 16×MG; 16×AF3;
Assess
Human TRiC complex in closed state with nanobody and tubulin bound Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13885; Q99832;
2-539
16×ADP; 16×MG; 16×AF3;
Assess
Human TRiC-tubulin-S3 Heteromer
P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
6-540
16×ADP; 16×MG; 16×AF3;
Assess
cryo-EM structure of human TRiC-ADP-AlFx Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
6-540
16×ADP; 16×MG; 16×AF3;
Assess
cryo-EM structure of human TRiC-ATP-closed state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
6-540
Assess
Human TRiC complex in closed state with nanobody bound (Consensus Map) Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
3-536
16×ADP; 16×MG; 16×AF3;
Assess
The beta-tubulin folding intermediate IV Heteromer
P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
11-538
MG;ADP;AF3;
Assess
The beta-tubulin folding intermediate III Heteromer
P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
11-538
MG;ADP;AF3;
Assess
The beta-tubulin folding intermediate II Heteromer
P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
11-538
AF3;MG;ADP;
Assess
Human TRiC/CCT complex with reovirus outer capsid protein sigma-3 Heteromer
P03527; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
12-538
ZN;
Assess
Human TRiC in ATP/AlFx closed state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
12-538
Assess
The beta-tubulin folding intermediate I Heteromer
P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
11-537
MG;ADP;AF3;
Assess
Human TRiC-PhLP2A-actin complex in the closed state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P60709; P78371; Q99832; Q9H2J4;
12-538
Assess
Human TRiC-PhLP2A complex in the closed state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; Q9H2J4;
12-536
16×ADP; 16×MG; 16×AF3;
Assess
Cryo-EM structure of human TRiC-tubulin-S2 Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
20-539
16×ATP;
Assess
Cryo-EM structure of human TRiC-NPP state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
20-539
Assess
cryo-EM structure of human TRiC-ADP Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
20-539
16×ADP;
Assess
Cryo-EM structure of Human TRiC-ATP-open state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
20-539
Assess
Human CCT:mLST8 complex Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
22-541
ADP;
Assess
Open state CCT-G beta 5 complex Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
22-541
16×ADP;
Assess
Human TRiC open state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
20-539
ADP;
Assess
hTRiC-hPFD Class1 (No PFD) Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
25-541
Assess
hTRiC-hPFD Class3 Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
25-541
Assess
Negative-stain electron microscopy structure of DDB1-DCAF12-CCT5 Heteromer
P48643; Q16531; Q5T6F0;
25-541
Assess
hTRiC-hPFD Class4 Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
25-541
Assess
hTRiC-hPFD Class5 Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
25-541
Assess
hTRiC-hPFD Class2 Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
25-541
Assess
hTRiC-hPFD Class6 Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
25-541
Assess
Human TRiC-PhLP2A complex in the open state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; Q9H2J4;
25-537
10×ADP;
Assess
Cryo-EM structure of human TRiC-tubulin-S1 state Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
25-536
ADP;
Assess
Human TRiC complex in open state with nanobody bound Heteromer
P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
26-536
16×MG; 16×ADP; 12×AF3;
Assess
Prefoldin-tubulin-TRiC complex Heteromer
O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
28-533
ADP;
Assess
Structure of human DDB1-DCAF12 in complex with the C-terminus of CCT5 Heteromer
P48643; Q16531; Q5T6F0;
537-541
Assess
Structure of Human T-complex protein 1 subunit epsilon (CCT5) mutant His147Arghomo-16-mer29-536
16×ADP; 12×MG;
Assess
Structure of Human T-complex protein 1 subunit epsilon (CCT5)homo-16-mer31-536
16×ADP;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7nvm.1.Mmonomer0.782-541
ADP;MG;AF3;100.00
Assess